COST-EFFECTIVENESS OF BAZEDOXIFENE IN THE UK AND SWEDEN INCORPORATING THE FRAX®-ALGORITHM

被引：0
|
作者：
Strom, O. [1 ,2 ]
Coelho, J. [1 ]
Borgstrom, F. [1 ,2 ]
Mccloskey, E. [3 ]
Oden, A. [4 ]
Johansson, H. [4 ]
Kanis, J. [4 ]
机构：
[1] I3 Innovus, Stockholm, Sweden
[2] Karolinska Inst, Med Management Ctr, Stockholm, Sweden
[3] No Gen Hosp, Osteoporosis Ctr, Sheffield S5 7AU, S Yorkshire, England
[4] Univ Sheffield, WHO Collaborating Ctr, Sheffield, S Yorkshire, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective
    F. Borgström
    O. Ström
    M. Kleman
    E. McCloskey
    H. Johansson
    A. Odén
    J. A. Kanis
    [J]. Osteoporosis International, 2011, 22 : 955 - 965
  • [2] Cost-effectiveness of bazedoxifene incorporating the FRAXA® algorithm in a European perspective
    Borgstrom, F.
    Strom, O.
    Kleman, M.
    McCloskey, E.
    Johansson, H.
    Oden, A.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 955 - 965
  • [3] COST-EFFECTIVENESS MODEL FOR DENOSUMAB INCORPORATING FRAX® AND ADHERENCE IN A UK SETTING
    Strom, O.
    Macarios, D.
    Badamgarav, E.
    Borgstrom, F.
    Jonsson, B.
    Tosteson, A.
    Kanis, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 20 - 20
  • [4] Incorporating FRAX™ Algorithms in Models of Cost-effectiveness
    Stroem, O.
    Borgstroem, F.
    McCloskey, E.
    Anders, O.
    Johansson, H.
    Kanis, J. A.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S8 - S8
  • [5] Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm
    Kim, K.
    Svedbom, A.
    Luo, X.
    Sutradhar, S.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (01) : 325 - 337
  • [6] Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm
    K. Kim
    A. Svedbom
    X. Luo
    S. Sutradhar
    J. A. Kanis
    [J]. Osteoporosis International, 2014, 25 : 325 - 337
  • [7] The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
    F. Borgström
    O. Ström
    J. Coelho
    H. Johansson
    A. Oden
    E. V. McCloskey
    J. A. Kanis
    [J]. Osteoporosis International, 2010, 21 : 495 - 505
  • [8] COST-EFFECTIVENESS OF BAZEDOXIFENE VS. RALOXIFENE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS USING FRAX® IN EUROPEAN COUNTRIES
    Svedbom, Axel
    Luo, Xuemei
    Kanis, John
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S65 - S65
  • [9] Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
    O. Ström
    B. Jönsson
    J. A. Kanis
    [J]. Osteoporosis International, 2013, 24 : 1491 - 1502
  • [10] COST-EFFECTIVENESS OF BAZEDOXIFENE VS. RALOXIFENE AMONG SUBGROUPS OF POSTMENOPAUSAL WOMEN WITH DIFFERENT FRACTURE RISKS ASSESSED BY FRAX®
    Luo, Xuemei
    Svedbom, Axel
    Kim, Kun
    Sutradhar, Santosh
    Kanis, John A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S349 - S350
12345